# Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms

> **NCT07027943** · NA · COMPLETED · sponsor: **AB Biotek** · enrollment: 108 (actual)

## Conditions studied

- Insomnia
- Insomnia Type; Sleep Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** DAO supplement
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07027943
- **Lead sponsor:** AB Biotek
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-13
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07027943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07027943, "Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07027943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*